In primary breast cancer, mutations of the p53 tumor suppressor gene lead to loss of growth-suppressive properties and poor outcome. Recently, a p53-related gene, termed p73, has been cloned and its gene product possesses a function similar to p53. p73 has been mapped at chromosome 1p36.3, a region
Impaired BAX protein expression in breast cancer: Mutational analysis of the BAX and the p53 gene
✍ Scribed by Isrid Sturm; Sarantos Papadopoulos; Timo Hillebrand; Thomas Benter; Hans-Joachim Lück; Gerhard Wolff; Bernd Dörken; Peter T. Daniel
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 85 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The histological characteristics of phyllodes tumours of the breast are often not related to their clinical outcome. Additional studies must therefore be performed to investigate the possible relationship of cell biological parameters to the biological behaviour of these tumours. The expression of K
The number and diversity of mutations in the p53 muta-smoke component benzo [a]pyrene representing the tion data base provides indirect evidence that impli-polycyclic aromatic hydrocarbon class of carcinogens. cates environmental mutagens in human carcinogene-The damage/repair data obtained for thes
Resistance to apoptosis plays an important role in malignancies that are refractory to chemotherapy treatment. Recently we have shown that the expression of bax-a, a death-promoting member of the bcl-2 family, is down-regulated in breast cancer and have provided evidence that low bax expression migh
Mutation of the p53 gene is found in about one third of astrocytic brain tumors, and expansion of tumor cell clones containing mutant p53 has been implicated in astrocytic tumor progression. However, admixture of normal cells in astrocytic tumor specimens limits the power of traditional studies of t